|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| C12N 9/52 | |||
| C07K 14/33 |
| (11) | Number of the document | 2854840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13714747.6 |
| Date of filing the European patent application | 2013-03-13 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/030737 |
| Date | 2013-03-13 |
| (87) | Number | WO 2013/180799 |
| Date | 2013-12-05 |
| (30) | Number | Date | Country code |
| 201261653214 P | 2012-05-30 | US |
| (72) |
STENMARK, Pål Erik Gustav, SE
BERNTSSON, Ronnie, Per-Arne, SE
DONG, Min, US
PENG, Lisheng, CN
|
| (73) |
President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
|
| (54) | ENGINEERED BOTULINUM NEUROTOXIN |
| ENGINEERED BOTULINUM NEUROTOXIN |